Web5. mar 2024 · Initial dose of 4 mg/kg as an intravenous infusion over 90 minutes then at 2 mg/kg as an intravenous infusion over 30 minutes weekly during chemotherapy for the first 12 weeks (paclitaxel or docetaxel) or 18 weeks (docetaxel/carboplatin). WebDOCEtaxel and CARBOplatin to be given every 21 days x 6cycles. trastuzumab to be given every 21 days x 6 cycles, followed by single agent trastuzumab (see BC Cancer protocol . …
Breast Cancer - Inflammatory: Types of Treatment Cancer.Net
Web31. aug 2015 · THP ( docetaxel, trastuzumab, and pertuzumab) is a chemotherapy regimen used to treat HER2-positive breast cancer. It contains these medicines: Docetaxel (Taxotere) – a type of chemotherapy medicine called a taxane Trastuzumab (Herceptin) – a type of targeted therapy called a monoclonal antibody Pertuzumab (Perjeta) – a type of … WebThe treatment regimen to be used should take into account factors such as histology, molecular pathology, age, performance status, co-morbidities and the patient’s preference. Each treatment regimen has advantages and disadvantages, and there may be more than one good option. facility mission statement
Docetaxel (Taxotere ®) and carboplatin Macmillan Cancer Support
Web21. sep 2016 · The beneficial combination of rhuMAb HER-2 antibody with platinum compounds (ie, cisplatin) has been disclosed previously. 19 The current TP regimen was the same as that used in the pivotal clinical trial evaluating the benefit of … Web23. nov 2024 · Traditional neoadjuvant systemic chemotherapy plus dual HER2-targeted blockade (docetaxel, carboplatin, and trastuzumab plus pertuzumab) resulted in significantly more patients achieving a … WebPerjeta Herceptin Taxol Quand et comment aurai-je mon traitement ? Le traitement sera administré en perfusion sur votre chambre implantable (ou PAC*). L’Herceptin peut être … does the body make vitamin c